Introduction
The medical device manufacturing industry in India has received considerable attention with a new development that marks the growth of the healthcare innovation and infrastructure in the country. Recently, a significant milestone was achieved when Shukra Pharmaceuticals received a letter of intent for 10 acres of land in the Medical Device Park in Sector 28, Greater Noida, from the Yamuna Expressway Industrial Development Authority (YEIDA).
This important development will help India’s growing position as a destination for innovative medical technologies, providing jobs and helping to reduce the country’s reliance on imports of high-end medical devices.
A New Era for Medical Device Manufacturing in India
A 10-acre land allotment was handed over to Shukra Pharmaceuticals for setting up an advanced manufacturing unit that would be centered on life-saving medical technologies.
Here’s what makes this development special:
Advanced Healthcare Product Manufacturing
The proposed facility will be used for the manufacture of a broad range of products, such as
- Radiology and imaging equipment such as CT scanners, MRI machines, PET scanners, ultrasound machines, and X-ray machines
- High-end therapeutic equipment, such as Boron Neutron Capture Therapy (BNCT) machine,s for treating cancer
- Intensive Care Unit (ICU) equipment, such as ventilators, anesthesia machines, and oxygen concentrators
- Cardiac implants such as heart valves, stents, and left ventricular assist devices
- Robotic surgical instruments for soft tissue, orthopedic, dental, and neurospine applications
- In-vitro diagnostics and point-of-care testing instruments
The above list indicates the scope of medical device manufacturing in India, which is being planned and executed strategically to include advanced medical devices.
Economic Impact and Employment Generation
The economic activities are being largely fueled by this initiative. The project, with an estimated investment of ₹587 crore, is set to create over 900 direct employment opportunities and about 2,000 indirect employment opportunities in different sectors such as manufacturing, research and development, quality control, and related services.
The establishment of this facility will not only improve the employment scenario in the region but also improve the medical technology innovation ecosystem in India.
Strategic Advantage of the Medical Device Park in Sector 28
The Medical Device Park in Sector 28, Greater Noida, is a dedicated industrial area that will attract investments from health-tech firms and promote the indigenous development of complex medical devices.
Extending over several hundred acres of land, this park is set to become a significant manufacturing destination in North India, with state-of-the-art infrastructure facilities that will help support the production of clinical technology.
The development of this park is adding to the strategic advantage of medical device manufacturing in India, as it is promoting innovation, investment, and economic development.
Conclusion
The allocation of land to Shukra Pharmaceuticals is a significant step in the right direction for the production of medical devices in India. With significant investment, employment opportunities, and a diversified product portfolio, the project is expected to enhance the Indian healthcare system and place India on the global map as a major producer of medical devices.
It is pertinent to note that international investors, such as ERM Global Investors, are also expected to take notice of the opportunities that emerge from such developments, as India has a strategic focus on healthcare innovation and manufacturing.
